Sean Higgins

Title: Innovations by Sean Higgins

Introduction

Sean Higgins is an accomplished inventor based in Alameda, CA. He has made significant contributions to the field of biotechnology, holding a total of 11 patents. His work focuses on gene editing and the development of innovative therapeutic methods.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Compositions and methods for the targeting of PCSK9." This patent describes gene repressor systems that utilize fusion proteins, including DNA binding domains such as TALE, zinc finger, or catalytically-dead CRISPR proteins, along with guide nucleic acids (gRNA). These systems are designed to repress the transcription of the PCSK9 gene, which plays a crucial role in cholesterol regulation. Another notable patent is for "Engineered guide scaffolds," which details engineered Class 2 Type V nucleases and guide RNAs that are useful for editing target nucleic acids. This invention provides methods for creating and utilizing these variants to modify nucleic acids effectively.

Career Highlights

Sean Higgins has established himself as a key figure in the biotechnology sector. His innovative approaches to gene editing and therapeutic development have garnered attention and respect within the scientific community. His work at Scribe Therapeutics Inc. has positioned him at the forefront of advancements in genetic research.

Collaborations

Sean collaborates with talented individuals such as Sarah Denny and Benjamin Oakes, contributing to a dynamic and innovative work environment. Their combined expertise fosters creativity and drives the development of cutting-edge technologies.

Conclusion

Sean Higgins is a notable inventor whose work in gene editing and biotechnology continues to impact the field significantly. His patents reflect a commitment to advancing medical science and improving therapeutic options.